JAZZ

Jazz Pharmaceuticals (JAZZ)

About Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Details

Daily high

$258.38

Daily low

$254.69

Price at open

$257.49

52 Week High

$265.04

52 Week Low

$109.87

Market cap

16.7B

Dividend yield

0.00%

Volume

970,710

Avg. volume

769,215

P/E ratio

17.70

Jazz Pharmaceuticals News